Clinical diagnostics

Infectious disease diagnostics

PlasmAcute plans to introduce novel immunoassay tests for infectious disease diagnostics, with performance comparable to molecular tests.

Clinical laboratories are reluctantly looking beyond established, easy-to-use diagnostic methods. New molecular tests are being adopted due to their higher sensitivity particularly in the first days or weeks after infection.

The PlasmAcute technology combines high sensitivity with early detection and the ease of use of well-established technology.